Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
AbbVie
Memorial Sloan Kettering Cancer Center
Hackensack Meridian Health
Ohio State University Comprehensive Cancer Center
Eli Lilly and Company
Acerta Pharma BV
Sana Biotechnology
City of Hope Medical Center
National Cancer Institute (NCI)
City of Hope Medical Center
City of Hope Medical Center
Sana Biotechnology
Jonsson Comprehensive Cancer Center
City of Hope Medical Center
Synthekine
Bio-Path Holdings, Inc.
Nkarta, Inc.
Malaghan Institute of Medical Research